Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancerQian Zhou, Liang Chen, Bo Li et al.|EMBO Molecular Medicine|2021Cited by 56
Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancerQian Zhou, Liang Chen, Wensheng Chen et al.|Theranostics|2021Cited by 30
FGFR inhibitors combined with nab-paclitaxel - A promising strategy to treat non-small cell lung cancer and overcome resistanceFeng Ma, Meng Xu|Frontiers in Oncology|2023Cited by 4
Heat Shock Factor 1 (HSF1) specifically potentiates c-MYC-mediated transcription independently of the canonical heat-shock responseMeng Xu, Chengkai Dai|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0